KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Treasury Shares: 2016-2023

Historic Treasury Shares for Moderna (MRNA) over the last 5 years, with Dec 2023 value amounting to $8.0 million.

  • Moderna's Treasury Shares fell 65.22% to $8.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $8.0 million, marking a year-over-year decrease of 65.22%. This contributed to the annual value of $8.0 million for FY2023, which is 65.22% down from last year.
  • Moderna's Treasury Shares amounted to $8.0 million in Q4 2023, which was down 0.00% from $8.0 million recorded in Q3 2023.
  • In the past 5 years, Moderna's Treasury Shares registered a high of $23.0 million during Q4 2022, and its lowest value of $1.0 million during Q1 2019.
  • For the 3-year period, Moderna's Treasury Shares averaged around $8.2 million, with its median value being $6.0 million (2022).
  • Per our database at Business Quant, Moderna's Treasury Shares spiked by 792.86% in 2022 and then slumped by 65.22% in 2023.
  • Over the past 5 years, Moderna's Treasury Shares (Quarterly) stood at $1.2 million in 2019, then skyrocketed by 86.03% to $2.2 million in 2020, then spiked by 36.99% to $3.0 million in 2021, then skyrocketed by 666.67% to $23.0 million in 2022, then tumbled by 65.22% to $8.0 million in 2023.
  • Its last three reported values are $8.0 million in Q4 2023, $8.0 million for Q3 2023, and $8.0 million during Q2 2023.